References
- Weiner E. S., Earnshaw W. C., Senecal J. L., Bordwell B., Johnson P., Rothfield N. F. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: a study of 355 patients. Arthritis Rheum 1988; 31: 378–85
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
- Thompson D., Juby A., Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993; 2: 15–19
- Reichlin M., Harley J. B. Antinuclear antibodies: an overview. Dubois' lupus erythematosus, 5th edn, D. J Wallace, B. H Hahn. Williams & Wilkins, Baltimore 1997; 397–405
- Caramaschi P., Biasi D., Manzo T., Carletto A., Poli F., Bambara L. M. Anticentromere antibody clinical associations. A study of 44 patients. Rheumatol Int 1995; 14: 253–5
- Goldmann J. A. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease. Ann Rheum Dis 1989; 48: 771–5
- Soma Y., Takehara K., Ishibashi Y. Clinical distribution of anticentromere antibody in Japanese patients. Dermatologica 1989; 178: 16–19
- Tubach F., Hayem G., Elias A., Nicaise P., Haim T., Kahn M. F., et al. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rhum Engl Ed 1997; 64: 362–7
- Insua Vilarino S., de la Hera Martinez M., Rodriguez‐Valverde V., Merino Perez J., Alonso Valdivieso J. L., Ruiz T. [The clinical spectrum of patients with anticentromere antibodies] in Spanish. Rev Clin Esp 1993; 192: 260–4
- Russo K., Hoch S., Dima C., Varga J., Teodorescu M. Circulating anticentromere CENP‐A and CENP‐B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2000; 27: 142–8
- Rothfield N. Autoantibodies in scleroderma. Rheum Dis Clin North Am 1992; 18: 483–98
- Subcommitee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)., Arthritis Rheum. 23. 581–90
- Nakano M., Ohuchi Y., Hasegawa H., Kuroda T., Ito S., Gejyo F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 2000; 27: 1403–7
- Amital H., Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. Systemic lupus erythematosus, 3rd edn, R. G Lahita. Academic Press, San Diego 1999; 1–16
- Ford A. L., Kurien B. T., Harley J. B., Scofield R. H. Anti‐centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma. J Rheumatol 1998; 25: 1419–24